S&P 500   4,575.87 (-1.71%)
DOW   34,525.79 (-1.74%)
QQQ   392.92 (-1.69%)
AAPL   163.39 (+1.97%)
MSFT   330.46 (-1.83%)
FB   326.19 (-3.50%)
GOOGL   2,850.01 (-2.08%)
AMZN   3,506.66 (-1.54%)
TSLA   1,129.91 (-0.62%)
NVDA   321.10 (-3.79%)
BABA   126.74 (-3.70%)
NIO   38.83 (-4.03%)
CGC   10.39 (-6.06%)
AMD   156.35 (-3.43%)
GE   94.51 (-3.95%)
MU   84.46 (-1.95%)
T   22.59 (-5.44%)
F   19.12 (-2.80%)
DIS   143.98 (-2.59%)
ACB   6.20 (-3.73%)
AMC   33.79 (-8.28%)
PFE   54.17 (+3.38%)
BA   194.55 (-1.99%)
S&P 500   4,575.87 (-1.71%)
DOW   34,525.79 (-1.74%)
QQQ   392.92 (-1.69%)
AAPL   163.39 (+1.97%)
MSFT   330.46 (-1.83%)
FB   326.19 (-3.50%)
GOOGL   2,850.01 (-2.08%)
AMZN   3,506.66 (-1.54%)
TSLA   1,129.91 (-0.62%)
NVDA   321.10 (-3.79%)
BABA   126.74 (-3.70%)
NIO   38.83 (-4.03%)
CGC   10.39 (-6.06%)
AMD   156.35 (-3.43%)
GE   94.51 (-3.95%)
MU   84.46 (-1.95%)
T   22.59 (-5.44%)
F   19.12 (-2.80%)
DIS   143.98 (-2.59%)
ACB   6.20 (-3.73%)
AMC   33.79 (-8.28%)
PFE   54.17 (+3.38%)
BA   194.55 (-1.99%)
S&P 500   4,575.87 (-1.71%)
DOW   34,525.79 (-1.74%)
QQQ   392.92 (-1.69%)
AAPL   163.39 (+1.97%)
MSFT   330.46 (-1.83%)
FB   326.19 (-3.50%)
GOOGL   2,850.01 (-2.08%)
AMZN   3,506.66 (-1.54%)
TSLA   1,129.91 (-0.62%)
NVDA   321.10 (-3.79%)
BABA   126.74 (-3.70%)
NIO   38.83 (-4.03%)
CGC   10.39 (-6.06%)
AMD   156.35 (-3.43%)
GE   94.51 (-3.95%)
MU   84.46 (-1.95%)
T   22.59 (-5.44%)
F   19.12 (-2.80%)
DIS   143.98 (-2.59%)
ACB   6.20 (-3.73%)
AMC   33.79 (-8.28%)
PFE   54.17 (+3.38%)
BA   194.55 (-1.99%)
S&P 500   4,575.87 (-1.71%)
DOW   34,525.79 (-1.74%)
QQQ   392.92 (-1.69%)
AAPL   163.39 (+1.97%)
MSFT   330.46 (-1.83%)
FB   326.19 (-3.50%)
GOOGL   2,850.01 (-2.08%)
AMZN   3,506.66 (-1.54%)
TSLA   1,129.91 (-0.62%)
NVDA   321.10 (-3.79%)
BABA   126.74 (-3.70%)
NIO   38.83 (-4.03%)
CGC   10.39 (-6.06%)
AMD   156.35 (-3.43%)
GE   94.51 (-3.95%)
MU   84.46 (-1.95%)
T   22.59 (-5.44%)
F   19.12 (-2.80%)
DIS   143.98 (-2.59%)
ACB   6.20 (-3.73%)
AMC   33.79 (-8.28%)
PFE   54.17 (+3.38%)
BA   194.55 (-1.99%)
NASDAQ:ISO

IsoPlexis Stock Forecast, Price & News

$11.80
-0.82 (-6.50%)
(As of 11/30/2021 01:15 PM ET)
Add
Compare
Today's Range
$11.56
$12.70
50-Day Range
N/A
52-Week Range
$10.23
$16.95
Volume
2,100 shs
Average Volume
153,622 shs
Market Capitalization
$459.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ISO News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.


IsoPlexis logo

About IsoPlexis

IsoPlexis Corporation is a life science technology company which build solutions for development of curative medicines and personalized therapeutics. IsoPlexis Corporation is based in BRANFORD, Conn.

Headlines

IsoPlexis (NASDAQ:ISO) Shares Up 12%
November 24, 2021 |  americanbankingnews.com
IsoPlexis (NASDAQ:ISO) Reaches New 52-Week High at $16.95
November 20, 2021 |  americanbankingnews.com
Analyst Ratings For IsoPlexis
November 19, 2021 |  markets.businessinsider.com
IsoPlexis (NASDAQ:ISO) Shares Gap Up to $15.20
November 19, 2021 |  americanbankingnews.com
IsoPlexis Q3 Sales $4.20M Beat $3.80M Estimate
November 12, 2021 |  benzinga.com
IsoPlexis Corp.
November 10, 2021 |  wsj.com
See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
N/A
Current Symbol
NASDAQ:ISO
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$459.73 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/10/2021
Today
11/30/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/09/2022

MarketRank

Overall MarketRank

1.70 out of 5 stars

Analytical Instruments Industry

22nd out of 33 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












IsoPlexis (NASDAQ:ISO) Frequently Asked Questions

Is IsoPlexis a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IsoPlexis in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IsoPlexis stock.
View analyst ratings for IsoPlexis
or view top-rated stocks.

When is IsoPlexis' next earnings date?

IsoPlexis is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for IsoPlexis
.

How were IsoPlexis' earnings last quarter?

IsoPlexis Corp (NASDAQ:ISO) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($10.66) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.79) by $9.87.
View IsoPlexis' earnings history
.

What price target have analysts set for ISO?

4 Wall Street analysts have issued 1-year price objectives for IsoPlexis' stock. Their forecasts range from $16.00 to $24.00. On average, they expect IsoPlexis' stock price to reach $20.00 in the next year. This suggests a possible upside of 72.0% from the stock's current price.
View analysts' price targets for IsoPlexis
or view top-rated stocks among Wall Street analysts.

When did IsoPlexis IPO?

(ISO) raised $125 million in an initial public offering on Friday, October 8th 2021. The company issued 8,333,000 shares at $14.00-$16.00 per share.

What is IsoPlexis' stock symbol?

IsoPlexis trades on the NASDAQ under the ticker symbol "ISO."

When did IsoPlexis' quiet period expire?

IsoPlexis' quiet period expired on Wednesday, November 17th. IsoPlexis had issued 8,333,000 shares in its IPO on October 8th. The total size of the offering was $124,995,000 based on an initial share price of $15.00. During IsoPlexis' quiet period, underwriters and any insiders that worked on the IPO were restricted from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of IsoPlexis?

Shares of ISO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IsoPlexis' stock price today?

One share of ISO stock can currently be purchased for approximately $11.63.

How much money does IsoPlexis make?

IsoPlexis has a market capitalization of $453.10 million.

How many employees does IsoPlexis have?

IsoPlexis employs 2,021 workers across the globe.

What is IsoPlexis' official website?

The official website for IsoPlexis is isoplexis.com.

Where are IsoPlexis' headquarters?

IsoPlexis is headquartered at 35 NE INDUSTRIAL ROAD, BRANFORD CT, 06405.

How can I contact IsoPlexis?

IsoPlexis' mailing address is 35 NE INDUSTRIAL ROAD, BRANFORD CT, 06405. The company can be reached via phone at 475-221-8402.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.